PhosPrints capabilities are improved by the laser bioprinting method.
PhosPrint has raised $2.1M in total funding. The most recent round was Grant. The last funding was announced in June 2022.
PhosPrint's investors include European Innovation Council.
PhosPrint is headquartered in Ayía Paraskeví, Greece.
PhosPrints capabilities are improved by the laser bioprinting method.
PhosPrint is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PhosPrint — Funding & Investors." VCBacked, June 15, 2022, https://www.vcbacked.co/company/phosprint. Accessed August 16, 2026.
VCBacked. (2022). PhosPrint — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/phosprint
{{cite web |title=PhosPrint — Funding & Investors |url=https://www.vcbacked.co/company/phosprint |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated